Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Periprostatic bupivacaine block for postoperative urethral catheter discomfort after transurethral prostatectomy
IRCT20141009019470N108Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of bupivacaine in postoperative pain and cystitis (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Pain. Started Feb 2021; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative paincystitis
Beyond the preview
Go deeper on IRCT20141009019470N108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141009019470N108.